|
MUL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.80122583515185E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.41007214185629E-12 |
| Normal-vs-Stage2 |
3.738800E-03 |
| Normal-vs-Stage3 |
1.24944499191315E-12 |
| Normal-vs-Stage4 |
1.79890546903039E-11 |
| Stage1-vs-Stage2 |
5.460700E-03 |
| Stage1-vs-Stage3 |
2.532200E-01 |
| Stage1-vs-Stage4 |
2.955900E-02 |
| Stage2-vs-Stage3 |
1.177690E-03 |
| Stage2-vs-Stage4 |
4.167100E-04 |
| Stage3-vs-Stage4 |
2.130400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94289029309402E-14 |
| Normal-vs-AfricanAmerican |
2.06799999999951E-05 |
| Normal-vs-Asian |
3.03160000003633E-06 |
| Caucasian-vs-AfricanAmerican |
5.496000E-01 |
| Caucasian-vs-Asian |
1.080200E-01 |
| AfricanAmerican-vs-Asian |
5.803600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.96529467647133E-11 |
| Normal-vs-Female |
2.88502555179093E-12 |
| Male-vs-Female |
5.120800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.20500284697778E-11 |
| Normal-vs-Age(41-60Yrs) |
1.91429982976388E-10 |
| Normal-vs-Age(61-80Yrs) |
3.12599945928582E-11 |
| Normal-vs-Age(81-100Yrs) |
9.337300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.614800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.126400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.952800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.557400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.066800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.857600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.879800E-03 |
| Classical-VS-Follicular |
5.387400E-01 |
| Classical-VS-Other |
5.766000E-02 |
| Classical-VS-Normal |
1.70341518668238E-12 |
| Tall-VS-Follicular |
4.164900E-03 |
| Tall-VS-Other |
6.375600E-01 |
| Tall-VS-Normal |
1.52210466453084E-11 |
| Follicular-VS-Other |
1.481450E-01 |
| Follicular-VS-Normal |
1.38360000001558E-06 |
| Other-VS-Normal |
3.77970000000616E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51710000118044E-09 |
| Normal-vs-N1 |
4.36428670980149E-13 |
| N0-vs-N1 |
7.69260000000882E-05 |
|
|
